Madrid, Spain

Pilar Goya


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Pilar Goya

Introduction

Pilar Goya, an accomplished inventor based in Madrid, Spain, has made significant contributions to the field of pharmacology. With a focus on developing innovative compounds, her work has the potential to advance pain management therapies.

Latest Patents

Pilar Goya holds a patent for "Arylamide derivatives having multimodal activity against pain." This invention relates to arylamide derivatives that exhibit dual pharmacological activity targeting both the α2δ subunit of voltage-gated calcium channels and the μ-opioid receptor. This groundbreaking work is crucial for creating effective pharmaceutical compositions aimed at treating various types of pain.

Career Highlights

Goya is currently employed at Esteve Pharmaceuticals, S.A., where she applies her expertise to develop novel therapeutic solutions. Her continued research in the pharmaceutical industry underscores her commitment to enhancing patient care through innovative drug development.

Collaborations

Throughout her career, Pilar has collaborated with several talented professionals, including Antoni Torrens-Jover and Carmen Almansa-Rosales. These collaborations reflect her ability to work effectively within a team to foster creativity and innovation in the development of new therapeutics.

Conclusion

Pilar Goya is a leading figure in the innovative landscape of pharmacology, particularly in pain management. Her groundbreaking patent reflects her dedication to advancing medical science and improving the quality of life for patients. Through her work at Esteve Pharmaceuticals and her collaborations with esteemed colleagues, she continues to pave the way for future advancements in drug therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…